Comprehensive analysis of gene expression profiles in keratinocytes from patients with generalized atrophic benign epidermolysis bullosa

Experimental Dermatology

Volumn 11, Issue 1, 2002, Pages 75-81

  Huber, Ariana ^a   Yee, Carole ^a   Darling, Thomas N ^b   Yancey, Kim B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Bullous disease; cDNA microarrays; Collagen; Gene expression; Nonsense mediated mRNA decay trans acting factor

Indexed keywords

COLLAGEN TYPE 17; COMPLEMENTARY DNA; MESSENGER RNA; NONSENSE MEDIATED MESSENGER RNA DECAY TRANS ACTING FACTOR; RNA; TRANS ACTING FACTOR; UNCLASSIFIED DRUG; AUTOANTIGEN; BPAG1 PROTEIN, HUMAN; CARRIER PROTEIN; COLLAGEN; CYTOSKELETON PROTEIN; NERVE PROTEIN; NMD F PROTEIN, HUMAN; NMD-F PROTEIN, HUMAN; NONFIBRILLAR COLLAGEN; TRANSACTIVATOR PROTEIN;

ARTICLE; CELL CULTURE; CLINICAL ARTICLE; COLLAGEN 17A1 GENE; COMPARATIVE GENOMIC HYBRIDIZATION; COMPARATIVE STUDY; COMPUTER PROGRAM; CONTROLLED STUDY; DENSITOMETRY; DNA MICROARRAY; EPIDERMOLYSIS BULLOSA; EXPRESSED SEQUENCE TAG; GENE; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE MUTATION; GENERALIZED ATROPHIC BENIGN EPIDERMOLYSIS BULLOSA; GENETIC ANALYSIS; GENETIC CODE; GENETIC SCREENING; HOMOZYGOTE; HUMAN; HUMAN CELL; KERATINOCYTE; MUTANT; NULL MUTATION; QUANTITATIVE GENETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; TRANSCRIPTION REGULATION; UPREGULATION; ATROPHY; COMPUTER SYSTEM; GENETICS; PATHOLOGY; PHYSIOLOGY; REFERENCE VALUE;

ATROPHY; AUTOANTIGENS; CARRIER PROTEINS; CELLS, CULTURED; COLLAGEN; COMPUTER SYSTEMS; CYTOSKELETAL PROTEINS; EPIDERMOLYSIS BULLOSA; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; KERATINOCYTES; NERVE TISSUE PROTEINS; NON-FIBRILLAR COLLAGENS; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANS-ACTIVATORS; UP-REGULATION;

EID: 0036480874     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0625.2002.110108.x     Document Type: Article

References (17)

1. Hintner H, Wolff K. Generalized atrophic benign epidermolysis bullosa. Arch Derm 1982: 118: 375-384.
2. Darling T N, Bauer J W, Hintner H, Yancey K B. Generalized atrophic benign epidermolysis bullosa. Adv Dermatol 1998: 13: 87-119.
3. Diaz L A, Ratrie H III, Saunders W S et al. Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera: Immunolocalization of this protein to the hemisdesmosome. J Clin Invest 1990: 86: 1088-1094.
4. Li K, Tamai K, Tan E M L, Uitto J. Cloning of type XVII collagen: Complementary and genomic sequences of mouse 180-kDa bullous pemphigoid antigen (BPAG2) predict an interrupted collagenous domain, a transmembranous segment, and unusual features in the 5-prime end of the gene and the 3-prime-untranslated region of the mRNA. J Biol Chem 1993: 268: 8825-8834.
5. Hirako Y, Usukura J, Nishizawa Y, Owaribe K. Demonstration of the molecular shape of BP180, a 180-kDa bullous pemphigoid antigen, and its potential for trimer formation. J Biol Chem 1996: 271: 13739-13745.
6. Masunaga T, Shimizu H, Yee C, Borradori L, Nishikawa T, Yancey K B. The extracellular domain of BPAG2 localizes to anchoring filaments and its carboxyl terminus extends to the lamina densa of ormal human epidermal basement membrane. J Invest Dermatol 1997: 109: 200-206.
7. McGrath J A, Darling T N, Gatalica B, et al. A homozygous deletion mutation in the gene encoding the 180-kDa bullous pemphigoid antigen (BPAG2) in a family with generalized atrophic benign epidermolysis bullosa. J Invest Dermatol 1996: 106: 771-774.
8. Darling T N, McGrath J A, Gatalica B et al. Premature termination codons are present on both alleles of the bullous pemphigoid antige 2/type XVII collagen gene in five Austrian families with generalized atrophic benign epidermolysis bullosa. J Invest Dermatol 1997: 108: 463-468.
9. Darling T N, Koh B, Bale S J et al. A deletion mutation in COL17A1 in five Austrian families with generalized atrophic benign epidermolysis bullosa represents propagation of an ancestral allele. J Invest Dermatol 1998: 110: 170-173.
10. Darling T N, Yee C, Bauer J W, Hintner H, Yancey K B. Revertant mosaicism: Partial correction of a germ-line mutation in COL17 A1 by a frame-restoring mutation. J Clin Invest 1999: 103: 1371-1377.
11. Segade F, Gomez-Marquez J. Prothymosin alpha. Int J Biochem Cell Biol 1999: 11: 1243-1248.
12. Darling T N, Koh B, Yancey K B. Delineation of genes expressed in human epidermis by large-scale sequencing of a cDNA library generated from laser capture microdissected skin. J Invest Dermatol 1999: 112: 635 [abstract].
13. Maquat L E. When cells stop making sense. Effects of nonsense codons on RNA metabolism in vertebrate cells. RNA 1995: 1: 453-465.
14. Maquat L E. Defects in RNA splicing and the consequences of shortened translational reading frames. Am J Hum Genet 1996: 59: 279-286.
15. Darling T N, Yee C, Koh B et al. Cycloheximide facilates the identification of aberrant transcripts resulting from a novel splice-site mutations in COL17 A1 in a patient with generalized atrophic benign epidermolysis bullosa. J Invest Dermatol 1998: 110: 165-169.
16. Applequist S E, Selg M, Raman C, Jack H M. Cloning and characterization of HUPF1, a human homolog of the Saccharomyces cerevisiae nonsense mRNA-reducing UPF1 protein. Nucl Acids Res 1997: 25: 814.
17. Perlick H A, Medghalchi S M, Spencer F A, Kendzior R J Jr, Dietz H C. Mammalian orthologues of a yeast regulator of nonsense transcript stability. Proc Natl Acad Sci USA 1996: 93: 10928-10932.